Literature DB >> 671319

Asymmetry of the hexose transfer system in human erythrocytes. Comparison of the effects of cytochalasin B, phloretin and maltose as competitive inhibitors.

D A Basketter, W F Widdas.   

Abstract

1. Cytochalasin B inhibits glucose transfer in human red cells. With glucose exit the inhibition is typically non-competitive, but hexose exchange is competitively inhibited. 2. At 16 degrees C the inhibitory constant for inhibition of 3-O-methyl glucose exchange is estimated at 1.1 X 10(-7) M while that for inhibition of glucose exit is 5.0 X 10(-7) M. 3. Uptake of labelled Cytochalasin B includes a saturable component which when correlated with the inhibition of exchange corresponds to a maximal binding of ca. 2.4 X 10(5) molecules per cell. 4. The kinetic parameters are compared with those for maltose (a competitive inhibitor acting on the outside only) and phloretin (an inhibitor acting both inside and out). 5. Kinetic evidence suggests that Cytochalasin B reacts with the inside of the hexose transfer system and that the anomalous inhibitory characteristics are due to the chemical asymmetry of the system. Independent evidence in support of this view is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 671319      PMCID: PMC1282356          DOI: 10.1113/jphysiol.1978.sp012311

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  17 in total

1.  Variations of the parameters of glucose transfer across the human erythrocyte membrane in the presence of inhibitors of transfer.

Authors:  A K SEN; W F WIDDAS
Journal:  J Physiol       Date:  1962-03       Impact factor: 5.182

2.  Determination of the temperature and pH dependence of glucose transfer across the human erythrocyte membrane measured by glucose exit.

Authors:  A K SEN; W F WIDDAS
Journal:  J Physiol       Date:  1962-03       Impact factor: 5.182

3.  Glucose transport inhibition by proteolytic degradation of the human erythrocyte membrane inner surface.

Authors:  S J Masiak; P G LeFevre
Journal:  Biochim Biophys Acta       Date:  1977-03-01

4.  The asymmetry of the facilitated transfer system for hexoses in human red cells and the simple kinetics of a two component model.

Authors:  G F Baker; W F Widdas
Journal:  J Physiol       Date:  1973-05       Impact factor: 5.182

5.  Preferential uptake of D-glucose by isolated human erythrocyte membranes.

Authors:  A Kahlenberg; B Urman; D Dolansky
Journal:  Biochemistry       Date:  1971-08-03       Impact factor: 3.162

6.  Competitive inhibition of hexose transfer in human erythrocytes by Cytochalasin B [proceedings].

Authors:  D A Basketter; W F Widdas
Journal:  J Physiol       Date:  1977-02       Impact factor: 5.182

7.  Biochemical studies on the mode of action of cytochalasin B. Cytochalasin B binding to red cell membrane in relation to glucose transport.

Authors:  S Lin; J A Spudich
Journal:  J Biol Chem       Date:  1974-09-25       Impact factor: 5.157

8.  Asymmetry of the hexose transfer system in human erythrocytes. Experiments with non-transportable inhibitors.

Authors:  G F Baker; D A Basketter; W F Widdas
Journal:  J Physiol       Date:  1978-05       Impact factor: 5.182

9.  Interaction between phloretin and the red blood cell membrane.

Authors:  M L Jennings; A K Solomon
Journal:  J Gen Physiol       Date:  1976-04       Impact factor: 4.086

10.  LOCALIZATION OF ERYTHROCYTE MEMBRANE SULFHYDRYL GROUPS ESSENTIAL FOR GLUCOSE TRANSPORT.

Authors:  J VANSTEVENINCK; R I WEED; A ROTHSTEIN
Journal:  J Gen Physiol       Date:  1965-03       Impact factor: 4.086

View more
  43 in total

Review 1.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

2.  Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1.

Authors:  Kathryn E Hamilton; Janelle F Rekman; Leesha K Gunnink; Brianna M Busscher; Jordan L Scott; Andrew M Tidball; Nathan R Stehouwer; Grace N Johnecheck; Brendan D Looyenga; Larry L Louters
Journal:  Biochimie       Date:  2018-05-29       Impact factor: 4.079

3.  Targeting breast cancer with sugar-coated carbon nanotubes.

Authors:  Cale D Fahrenholtz; Mallinath Hadimani; S Bruce King; Suzy V Torti; Ravi Singh
Journal:  Nanomedicine (Lond)       Date:  2015-08-21       Impact factor: 5.307

4.  Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1.

Authors:  Richard J Naftalin; Iram Afzal; Philip Cunningham; Mansur Halai; Clare Ross; Naguib Salleh; Stuart R Milligan
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

5.  Role of tryptophan-388 of GLUT1 glucose transporter in glucose-transport activity and photoaffinity-labelling with forskolin.

Authors:  H Katagiri; T Asano; H Ishihara; J L Lin; K Inukai; M F Shanahan; K Tsukuda; M Kikuchi; Y Yazaki; Y Oka
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

6.  Asymmetry of hexose transfer system in erythrocytes of fetal and new-born guinea-pigs.

Authors:  D S Aubby; W F Widdas
Journal:  J Physiol       Date:  1980-12       Impact factor: 5.182

7.  Sugar transport in giant barnacle muscle fibres.

Authors:  A Carruthers
Journal:  J Physiol       Date:  1983-03       Impact factor: 5.182

8.  Dexamethasone inhibits the hexose monophosphate shunt in activated rat peritoneal macrophages by reducing hexokinase-dependent sugar uptake.

Authors:  R J Rist; R J Naftalin
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

9.  Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites.

Authors:  S M Jarvis; D McBride; J D Young
Journal:  J Physiol       Date:  1982-03       Impact factor: 5.182

10.  Characterization of sugar transport in the pigeon red blood cell.

Authors:  T J Simons
Journal:  J Physiol       Date:  1983-05       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.